Paul E. Miller

2.2k total citations
64 papers, 1.6k citations indexed

About

Paul E. Miller is a scholar working on Molecular Biology, Ophthalmology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Paul E. Miller has authored 64 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 27 papers in Ophthalmology and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Paul E. Miller's work include Glaucoma and retinal disorders (14 papers), Retinal Diseases and Treatments (13 papers) and Cardiac electrophysiology and arrhythmias (12 papers). Paul E. Miller is often cited by papers focused on Glaucoma and retinal disorders (14 papers), Retinal Diseases and Treatments (13 papers) and Cardiac electrophysiology and arrhythmias (12 papers). Paul E. Miller collaborates with scholars based in United States, Australia and Switzerland. Paul E. Miller's co-authors include J. Phillip Pickett, Andre Ghetti, Najah Abi‐Gerges, Amy M. Knollinger, Paul M. Barrett, Ilene D. Kurzman, Lynda J. Majors, Guy Page, Louis Rakita and T Vrobel and has published in prestigious journals such as Cancer Research, Gut and Scientific Reports.

In The Last Decade

Paul E. Miller

61 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul E. Miller United States 22 460 444 312 224 203 64 1.6k
Sandra Marchese Johnson United States 18 166 0.4× 247 0.6× 123 0.4× 68 0.3× 329 1.6× 51 1.5k
Graham R. Wallace United Kingdom 33 1.7k 3.8× 720 1.6× 316 1.0× 37 0.2× 78 0.4× 117 3.2k
Jae Ho Jung South Korea 16 293 0.6× 170 0.4× 334 1.1× 32 0.1× 35 0.2× 129 1.1k
Abdelhadi Saoudi France 32 87 0.2× 530 1.2× 151 0.5× 40 0.2× 62 0.3× 100 3.4k
Xiaowen L. Rudner United States 17 146 0.3× 387 0.9× 68 0.2× 73 0.3× 27 0.1× 26 1.3k
Joseph W. Sassani United States 24 700 1.5× 356 0.8× 593 1.9× 20 0.1× 29 0.1× 90 1.9k
David Goldblum Switzerland 29 1.8k 3.9× 639 1.4× 948 3.0× 21 0.1× 128 0.6× 125 2.8k
Shahin Yazdani Iran 32 2.2k 4.9× 504 1.1× 1.5k 4.9× 34 0.2× 125 0.6× 159 3.3k
Seema Garg India 17 208 0.5× 126 0.3× 123 0.4× 56 0.3× 144 0.7× 65 903
José D. Luna Argentina 25 1.3k 2.8× 690 1.6× 696 2.2× 23 0.1× 19 0.1× 73 2.1k

Countries citing papers authored by Paul E. Miller

Since Specialization
Citations

This map shows the geographic impact of Paul E. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Miller more than expected).

Fields of papers citing papers by Paul E. Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Miller. The network helps show where Paul E. Miller may publish in the future.

Co-authorship network of co-authors of Paul E. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Paul E. Miller. A scholar is included among the top collaborators of Paul E. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul E. Miller. Paul E. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gaidarov, Ibragim, H. Kiyomi Komori, Dariusz Stepniak, et al.. (2024). Unique pharmacological properties of etrasimod among S1P receptor modulators. FEBS Open Bio. 15(1). 108–121. 4 indexed citations
2.
Miller, Paul E., et al.. (2022). Characterization and Potential Mitigation of Corneal Effects in Nonclinical Toxicology Studies in Animals Administered Depatuxizumab Mafodotin. Journal of Ocular Pharmacology and Therapeutics. 38(7). 471–480. 8 indexed citations
3.
Komáromy, András M., Douglas W Esson, Ronald L. Fellman, et al.. (2019). The future of canine glaucoma therapy. Veterinary Ophthalmology. 22(5). 726–740. 45 indexed citations
4.
Sinclair, John G., Hong Liang, Paul E. Miller, et al.. (2019). Chronic Nonclinical Ocular Toxicity Study of KSI-301 Demonstrates Tolerability after Intravitreal Administration in Cynomolgus Monkeys. Investigative Ophthalmology & Visual Science. 60(9). 126–126. 1 indexed citations
5.
Meng, Jianghui, Masaki Moriyama, M Feld, et al.. (2018). New mechanism underlying IL-31–induced atopic dermatitis. Journal of Allergy and Clinical Immunology. 141(5). 1677–1689.e8. 135 indexed citations
6.
Booler, Helen, Nardos G. Tassew, Hong Liu, et al.. (2018). In vivo Effects of CCFD9260S Following Intravitreal Administration to Cynomolgus Monkeys. Investigative Ophthalmology & Visual Science. 59(9). 80–80. 1 indexed citations
7.
Miron, Yannick, Paul E. Miller, A. Ghetti, et al.. (2018). LB1511 Neuronal responses elicited by interleukin-13 in human neurons. Journal of Investigative Dermatology. 138(9). B8–B8. 5 indexed citations
8.
Bantseev, Vladimir, et al.. (2017). Nonclinical Safety Assessment of Anti-Factor D: Key Strategies and Challenges for the Nonclinical Development of Intravitreal Biologics. Journal of Ocular Pharmacology and Therapeutics. 34(1-2). 204–213. 10 indexed citations
9.
Ye, Guo-jie, Ewa Budzynski, T. Michael Nork, et al.. (2016). Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia. PubMed. 27(1). 27–36. 20 indexed citations
10.
Ye, Guo-jie, Ewa Budzynski, T. Michael Nork, et al.. (2016). Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia. PubMed. 27(1). 37–48. 53 indexed citations
11.
Zafra, Christina L. Zuch de, Cindy Farman, Eric Wakshull, et al.. (2015). Repeat-dose intravitreal administration of a humanized monoclonal antibody is poorly tolerated in rabbits. Investigative Ophthalmology & Visual Science. 56(7). 3640–3640. 1 indexed citations
12.
Lam, Tim T., Paul E. Miller, Susan J. Howard, & T. Michael Nork. (2014). Validation of a Rabbit Model of Choroidal Neovascularization Induced by a Subretinal Injection of FGF-LPS. Investigative Ophthalmology & Visual Science. 55(13). 1204–1204. 5 indexed citations
13.
Yanochko, Gina M., Timothy Affolter, Mark Evans, et al.. (2014). Investigation of Ocular Events Associated with Taprenepag Isopropyl, a Topical EP2 Agonist in Development for Treatment of Glaucoma. Journal of Ocular Pharmacology and Therapeutics. 30(5). 429–439. 11 indexed citations
14.
Mortellaro, Carlo M., et al.. (2009). Bilateral orbital and nasal aspergillosis in a cat. Veterinary Ophthalmology. 12(3). 176–182. 32 indexed citations
15.
Wiegand, Stanley J., T. Michael Nork, Paul E. Miller, et al.. (2005). VEGF Trap Both Prevents Experimental Choroidal Neovascularization and Causes Regression of Established Lesions in Non–Human Primates. Investigative Ophthalmology & Visual Science. 46(13). 1411–1411. 4 indexed citations
16.
Miller, Paul E., Christian Bueger, Joseph C. Beyer, et al.. (2003). 26-Week Intravitreal Injection Toxicity Study with rhuFab Vegf in Cynomolgus Monkeys with an 8-Week Recovery. Investigative Ophthalmology & Visual Science. 44(13). 3929–3929. 3 indexed citations
17.
Miller, Paul E., et al.. (1995). Mycobacterial keratitis in a parrot. Journal of the American Veterinary Medical Association. 206(8). 1177–1180. 6 indexed citations
18.
Miller, Paul E., et al.. (1994). Effects of experimentally induced hypothyroidism on the eye and ocular adnexa of dogs. American Journal of Veterinary Research. 55(5). 692–697. 9 indexed citations
19.
Miller, Paul E., J. Phillip Pickett, Lynda J. Majors, & Ilene D. Kurzman. (1991). Evaluation of two applanation tonometers in cats. American Journal of Veterinary Research. 52(11). 1917–1921. 118 indexed citations
20.
Miller, Paul E.. (1982). A Beginner's Guide to UNIX.. 323–325.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandra Marchese Johnson Breakdown of academic impact, for papers by Graham R. Wallace Breakdown of academic impact, for papers by Jae Ho Jung Breakdown of academic impact, for papers by Abdelhadi Saoudi Breakdown of academic impact, for papers by Xiaowen L. Rudner Breakdown of academic impact, for papers by Joseph W. Sassani Breakdown of academic impact, for papers by David Goldblum Breakdown of academic impact, for papers by Shahin Yazdani Breakdown of academic impact, for papers by Seema Garg Breakdown of academic impact, for papers by José D. Luna
Rankless by CCL
2026